Ranibizumabe Intravitreal Injection for Myopic Choroidal Neovascularization

NCT01246089 Phase 4 UNKNOWN

The purpose of this study is to evaluate the clinical results of anti-VEGF intra-vitreal injections (IVT) in CNV secondary to pathologic myopia (PM-CNV).

Details

Lead sponsor	Instituto de Olhos de Goiania
Phase	Phase 4
Status	UNKNOWN
Enrolment	20
Start date	2009-07
Completion	2014-11

Conditions

• Myopic Choroidal Neovascularization

Interventions

• ranibizumab injection

Countries

Brazil